CXCR2 and gastric cancer: For these reasons, our results suggest that FPR2, CARD14, CXCR2, EFNA2, CXCR1, AQP9 TRIP13, along with GHRL and KLK11, could be used as promising biomarkers for gastric cancer diagnosis or prognostic evaluation.